Morepen Labs.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE083A01026
  • NSEID: MOREPENLAB
  • BSEID: 500288
INR
42.57
-0.88 (-2.03%)
BSENSE

Dec 05

BSE+NSE Vol: 9.01 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
109.58
102.23
102.23
95.56
89.96
89.96
Share Warrants & Outstandings
Total Reserve
1,046.65
745.00
650.68
456.75
291.04
194.10
Shareholder's Funds
1,156.23
847.23
752.91
578.56
424.75
284.06
Minority Interest
30.73
0.00
-0.46
-0.46
-0.46
-0.46
Long-Term Borrowings
25.76
3.36
0.93
1.32
0.83
0.92
Secured Loans
5.76
3.36
0.93
1.32
0.83
0.92
Unsecured Loans
20.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
6.98
2.25
2.69
2.48
0.00
0.00
Other Long Term Liabilities
17.91
4.5
3.52
3.45
3.83
3.67
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
39.85
33.82
29.74
28.24
25.39
23.82
Total Non-Current Liabilities
90.49
43.93
36.88
35.50
30.06
28.42
Current Liabilities
Trade Payables
363.30
295.03
226.88
258.12
208.85
172.30
Other Current Liabilities
64.12
56.37
53.81
168.86
173.48
165.06
Short Term Borrowings
53.63
25.64
24.23
17.25
16.22
11.36
Short Term Provisions
19.60
25.02
16.24
12.24
5.25
2.72
Total Current Liabilities
500.65
402.04
321.16
456.46
403.80
351.44
Total Liabilities
1,778.10
1,293.21
1,110.50
1,070.05
858.15
663.46
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
791.10
620.63
656.24
613.25
628.32
752.55
Less: Accumulated Depreciation
328.07
313.28
389.27
361.45
403.79
536.18
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
463.03
307.35
266.97
251.80
224.52
216.37
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
28.34
24.45
17.01
14.15
1.96
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
7.17
1.30
0.00
0.00
1.08
1.08
Long Term Loans & Advances
94.47
70.82
70.07
69.53
103.52
71.31
Other Non Current Assets
0.23
0.24
0.28
0.28
0.27
2.52
Total Non-Current Assets
618.73
404.16
354.33
335.75
331.36
291.29
Current Assets Loans & Advances
Current Investments
77.81
0.00
0.00
0.00
0.00
0.00
Inventories
299.96
248.59
228.89
275.85
175.33
138.48
Sundry Debtors
324.76
324.94
263.25
250.64
181.98
137.68
Cash and Bank
49.36
52.12
56.31
45.97
67.89
38.88
Other Current Assets
70.34
14.88
6.17
4.71
9.43
5.42
Short Term Loans and Advances
337.14
248.51
201.56
157.12
92.16
51.72
Total Current Assets
1,159.37
889.04
756.16
734.30
526.79
372.18
Net Current Assets (Including Current Investments)
658.72
487.00
435.00
277.84
122.99
20.73
Total Current Assets Excluding Current Investments
1,081.56
889.04
756.16
734.30
526.79
372.18
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
1,778.10
1,293.21
1,110.50
1,070.05
858.15
663.46
Contingent Liabilities
18.32
9.76
6.66
2.64
0.93
1.27
Total Debt
79.39
29.00
25.16
18.57
17.05
12.28
Book Value per share (adjusted)
21.1
16.58
14.73
11.56
8.47
6.32
Balance Sheet Analysis Highlights
stock-summary

Borrowings

YoY Growth in year ended Mar 2025 is 173.76% vs 15.26% in Mar 2024

stock-summary

Other Long Term Liabilities

YoY Growth in year ended Mar 2025 is 298.00% vs 27.84% in Mar 2024

stock-summary

Fixed Assets

YoY Growth in year ended Mar 2025 is 48.09% vs 16.84% in Mar 2024

stock-summary

Investments

YoY Growth in year ended Mar 2025 is 451.54% vs 0.00% in Mar 2024

stock-summary

Current Assets

YoY Growth in year ended Mar 2025 is 30.41% vs 17.57% in Mar 2024

Compare Balance Sheet Results of Morepen Labs.
Markets Mojo
Figures in Cr
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
109.58
18.45
91.13
493.93%
Share Warrants & Outstandings
Total Reserve
1,046.65
997.81
48.84
4.89%
Shareholder's Funds
1,156.23
1,022.00
134.23
13.13%
Minority Interest
30.73
-3.62
34.35
948.90%
Long-Term Borrowings
25.76
620.54
-594.78
-95.85%
Secured Loans
5.76
620.54
-614.78
-99.07%
Unsecured Loans
20.00
0.00
20.00
0.00%
Deferred Tax Assets / Liabilities
6.98
13.36
-6.38
-47.75%
Other Long Term Liabilities
17.91
21.17
-3.26
-15.40%
Long Term Trade Payables
0.00
0.00
0.00
0.00%
Long Term Provisions
39.85
35.82
4.03
11.25%
Total Non-Current Liabilities
90.49
603.54
-513.05
-85.01%
Current Liabilities
Trade Payables
363.30
208.13
155.17
74.55%
Other Current Liabilities
64.12
109.88
-45.76
-41.65%
Short Term Borrowings
53.63
444.83
-391.20
-87.94%
Short Term Provisions
19.60
45.15
-25.55
-56.59%
Total Current Liabilities
500.65
807.99
-307.34
-38.04%
Total Liabilities
1,778.10
2,429.91
-651.81
-26.82%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
791.10
1,900.02
-1,108.92
-58.36%
Less: Accumulated Depreciation
328.07
918.05
-589.98
-64.26%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
463.03
981.97
-518.94
-52.85%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
28.34
276.12
-247.78
-89.74%
Intangible assets under development
0.00
44.42
-44.42
-100.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
7.17
1.46
5.71
391.10%
Long Term Loans & Advances
94.47
94.58
-0.11
-0.12%
Other Non Current Assets
0.23
15.11
-14.88
-98.48%
Total Non-Current Assets
618.73
1,428.58
-809.85
-56.69%
Current Assets Loans & Advances
Current Investments
77.81
0.00
77.81
0.00%
Inventories
299.96
419.35
-119.39
-28.47%
Sundry Debtors
324.76
352.41
-27.65
-7.85%
Cash and Bank
49.36
17.07
32.29
189.16%
Other Current Assets
70.34
64.18
6.16
9.60%
Short Term Loans and Advances
337.14
148.32
188.82
127.31%
Total Current Assets
1,159.37
1,001.34
158.03
15.78%
Net Current Assets (Including Current Investments)
658.72
193.34
465.38
240.71%
Total Current Assets Excluding Current Investments
1,081.56
1,001.34
80.22
8.01%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
1,778.10
2,429.91
-651.81
-26.82%
Contingent Liabilities
18.32
77.84
-59.52
-76.46%
Total Debt
79.39
895.21
-815.82
-91.13%
Book Value per share (adjusted)
21.10
110.79
-89.69
-80.95%
Annual - Borrowings
Borrowings 79.39 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 173.76% vs 15.26% in Mar 2024

Annual - Other Long Term Liabilities
Other Long Term Liabilities 17.91 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 298.00% vs 27.84% in Mar 2024

Annual - Fixed Assets
Fixed Assets 491.37 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 48.09% vs 16.84% in Mar 2024

Annual - Investments
Investments 7.17 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 451.54% vs 0.00% in Mar 2024

Annual - Current Assets
Current Assets 1,159.37 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 30.41% vs 17.57% in Mar 2024